There is a progressive rise in excretion of the metabolites of the estrogens (1) and of progesterone 1 (2) during pregnancy in humans. In late pregnancy, these hormones are largely placental in origin (3) (4) (5) (6) . The physiological role of the adrenal gland in pregnancy is still not well understood. The high levels of blood hydrocortisone found in pregnancy were initially explained as a reflection of an increased secretion of adrenal cortical hormones (7) . More recently, it has been shown that the high blood levels of hydrocortisone in pregnancy could be accounted for by the increased binding of this hormone to blood proteins (8) . It has been reported that aldosterone is secreted in increased amounts during pregnancy (9, 10) . From available evidence, it has been concluded that in humans aldosterone is not a secretory product of the placenta (11) (12) (13) (14) , but that it is formed in the adrenal gland.
In earlier studies (15) (16) (17) , bioassay of the crude urinary extract revealed little or no increase in the salt-retaining factor in pregnancy as compared with the normal nonpregnant state. Barnes and Quilligan (18) reported the same findings with a bioassay of urinary extracts purified by three paper chromatographic systems. In 1956, Venning and Dyrenfurth (19) from acid-hydrolyzed urine purified bv one paper chromatographic system and reported an increased level of aldosterone excretion in late pregnancy. At the same time, Martin and Mills (20) reported similar findings based on a physicochemical determination of aldosterone. Since then, several groups of investigators (21) (22) (23) (24) (25) have confirmed the earlier findings of an increased urinary excretion of acid-hvdirolyzable conjugate of aldosterone in pregnancy.
Although much valuable information has been obtained from the urinary excretion studies, a more precise knowledge of aldosterone secretion has awaited the development of isotopic procedures for the estimation of the rate of secretion of the hormone. Jones and associates (9) , using an isotope dilution method for aldosterone developed by Ayres and associates (26) , studied six pregnant subjects in the third trimester and found that three had elevated levels, whereas the others were within the range for normal nonpregnant females. In a preliminary study by Van de Weile and associates (10) , aldosterone secretion rates were found to be elevated in all three normal pregnant subjects studied.
In this study, aldosterone secretion rates were determined in a large number of subjects during the third trimester of pregnancy. It has been established that the secretory rate is consistently elevated in the third trimester and that it is responsive to changes in dietary sodium. The most striking alteration in the secretory rate can be elicited by lowering the dietary sodium.
METHODS
Subjects. All of the normal pregnant subj ects were ambulatory. Most of the subj ects were in a home for unwed mothers in Burlington, Vermont, under the supervision of the Department of Obstetrics and Gynecology of the University of Vermont. A small number of sub-jects were in the Women's Pavilion of the Royal Victoria Hospital in Montreal. The gestation time of the pregnancy was calculated from the first day of the last normal menstrual period. When the date of delivery was more than 3 weeks from the expected date of confinement, gestation was calculated from the date of delivery, provided that the fetus showed no evidence of pre-or postmaturity and that labor was spontaneous. All subjects except two were between 26 and 40 weeks of gestation. One subject was studied at 15 weeks just prior to a therapeutic abortion. A second subj ect was studied at 20 and 22 weeks because of a diagnosis of intrauterine fetal death. She was an epileptic with a history of eight previous fetal deaths, but on this occasion, pregnancy was carried to term with spontaneous delivery of a normal living infant.
Dietary intakc. The dietary sodium ingested by the pregnant subj ects was determined in several ways. Nine of the subjects were given a diet containing 50 mEq or less of sodium per day. These subj ects were placed on diets calculated to contain the amount of sodium required by the experimental design. For the 1 to 2 weeks of this restricted diet, no other food was ingested. In this greup of nine subjects, three ingested less than 10 mEq of sodium per day, and six ingested 25 to 50 mEq. Urinary sodium excretion was determined for the 2 days of aldosterone secretion rate in order to assess the adequacy of control of dietary sodium. In the three subjects ingesting less than 10 mEq of sodium per day, the average sodium ingested was 8 mEq, and the average urinary sodium excretion was 17.5 mEq per day. For the six subj ects receiving 25 to 50 mEq of sodium per day the urinary sodium paralleled the ingested sodium. An average of 84% of the ingested sodium was excreted in the urine.
For the rest of the subj ects studied, the dietary sodium was estimated by the dietitian attached to the home for unwed mothers in Burlington, Vermont. Each subj ect was instructed to keep a daily record of the food intake for 1 month. The sodium content of the diet for each subj ect was estimated from the knowledge of amount ingested, the source of the foods, and the methods employed in its preparation. The sodium content of the basal home diet was estimated to be between 150 and 170 mEq per day. The dietitian estimated that the error of the dietary sodium calculated in this manner was 25 to 40 per cent. Consequently, we have placed 51 subj ects into a group whose dietary sodium was estimated to be between 80 and 190 mEq with an over-all average of 150 mEq of sodium per day. In this group, the urinary sodium averaged 70% of the ingested sodium.
The constant dietary sodium intakes reported (Tables   VI and VII) were achieved by placing the subjects on the basal home diet as described above. During the period of study, the daily sodium intake was estimated by the dietitian.
In nine subjects, higher intake of sodium was attempted by the addition of sodium chloride (about 3 g per day) to the basal diet. A daily dietary sodium of over 190 mEq was achieved in this way in only four of these subjects; for them, the average sodium ingested was 209 mEq per day, and an average of 76% of this sodium was excreted in the urine.
Determination of radioactivity. Samples to be counted were evaporated under nitrogen in 5-dram vials 2 and dissolved in 5 ml of toluene containing 0.3%o of 2,5-diphenyloxazole (PPO) and 0.01%o of 1,4-bis-2-(5-phenyloxazolyl) benzene (POPOP). These samples were counted in a Packard Tri-Carb (model 314-X) liquid scintillation spectrophotometer with the counting chamber set at -20 C. The photomultiplier voltage tap was set at 5 (1,000 volts), and the pulse height discriminators were set at 10 to 100 (channel 1) and 100 to 00 (channel 2). The efficiency of tritium counting for channel 1 PPO: POPOP system, the discriminator ratio method of Okita, Kabara, Richardson, and Leroy (27) as modified by Ulick (28) was employed for separating the C14 and H3 counts. The "a" ratio (H3 counts in channel 2/ H3 counts in channel 1) was maintained between 0.018 and 0.024. The "b" ratio (C14 counts in channel 2/C14 counts in channel 1) was between 1.7 and 2.2.
Purification of aldosterone. Each lot of d-aldosterone7a-H3 (SA, 20 ,c per ,ug) 3 was tested for radiochemical purity by the following procedure. To a sample containing a known number of counts per minute was added a weighed amount of d-aldosterone. 4 The aldosterone was then chromatographed on successive paper systems, and the specific activity of the eluted steroid was determined at each stage by the blue tetrazolium reaction (29) on a measured sample. When a constant activity had been obtained for free aldosterone, it was acetylated with acetic anhydride-1-C14.5 The diacetate was then chromatographed on at least two systems until its specific activity was also constant, as determined by the H3/C14 ratio of the eluted steroid. The specific activities at the various stages of purification for the lots of aldosterone used in this study are shown in Table I (30) of aldosterone. After standing for 24 hours at room temperature, the urine was extracted with methylene chloride (0.5, 0.25, and 0.25 of the equivalent urine volume), the organic phase was processed as described above, and 10% of the neutral extract was taken for counting. A second 10% of each day's urine was hydrolyzed with B-gluctronidase as previously described (28) , and 10% was again taken for counting. The rest of the extracts from each day's urine after pH 1 hydrolysis and a-glucuronidase hydrolysis were chromatographed on paper. After pH 1 hydrolysis, the extract obtained was chromatographed in -the chloroform: formamide system for 3 to 4 hours, and -the area on the paper corresponding to the reference aldosterone was eluted and counted. After 8-glucuronidase hydrolysis, the resulting extract was chromatographed in the ethylene dichloride: formamide system until the isatin dye (2,3-indolinedione), used as marker, had migrated to the bottom of the paper. Tetrahydroaldosterone under these conditions has a migration rate of 0.6 to 0.8 of tetrahydrocortisone. The tetrahydroaldosterone was eluted and counted. The counts obtained were not corrected for losses incurred in the procedure.
Aldosterone secretion rates (ASR). Aldosterone secretion rates were determined by the isotope dilution technique described by Ulick, Laragh, and Lieberman (31) . Only minor modifications were made in the method as originally described. The specific activity of the tetrahydroaldosterone was obtained from the H3/C14 ratio of the triacetate formed after acetylation of the metabolite with previously standardized acetic anhydride-1-C14. Acetylation of desoxycorticosterone was used to standardize the acetic anhydride. Where a high ASR was anticipated, acetic anhydride assaying at 20 to 50 cpm per ag of desoxycorticosterone acetate was used, whereas for medium and low secretion rates, acetic anhydride having 75 and 100 cpm per lug, respectively, was more advantageous. Only when the H3/C14 ratio in the peak fraction and the two adjacent fractions from the final Celite partition chromatogram differed by less than 10% was the determination acceptable. The Celite partition column (cyclohexane: 85% methanol) could be used three times, after which the hold-back volume of the triacetate of tetrahydroaldosterone was too small.
The precision of the results obtained depends on the purity of the administered aldosterone and of the isolated urinary tetrahydroaldosterone. Ulick (28) has presented data demonstrating that the specific activity of tetrahydroaldosterone diacetate is constant after chromatography on paper in the methylcyclohexane: formamide system followed by Celite partition chromatography. We have extended these observations by measuring the specific activity of tetrahydroaldosterone in ten experiments after two consecutive chromatograms on the Celite partition column. The specific activity of tetrahydroaldosterone after the second chromatogram differed by less than 5%. Our counting error was not greater than 5%. Creatinine determination. Creatinine in serum and urine was determined by a modification of the method of Folin adapted to an autoanalyzer as developed by Skeggs (32) . In order to obtain adequate optical density readings from the low concentrations of serum creatinine encountered in pregnancy, the method was modified as follows. A sample rate of 20 per hour for serum and 40 per hour for urine was used in the autoanalyzer, and diluted serum was passed through two dialyzers in series. A vetting agent, Tween 20, was added to produce a more uniform rate of flow. The interfering chromogen encountered in serum is apparently bound to protein, since after dialysis in the autoanalyzer, excellent agreement is obtained with the Hare method (33), and a good recovery of creatinine added to synthetic sera is realized. Endogenous creatinine clearances were calculated from the two successive 24-hour urine collections used for the ASR.
Sodium determinations. Sodium in urine was measured by means of a Patwin flame photometer employing lithium as an internal standard.
RESULTS
Test of purity of the d-aldosterone-7a-Ha. Although the aldosterone-7a-H3 was said to be 96,% pure, it was tested for homogeneity in our laboratory. The specific activities obtained at the different stages of chromatography are shown in ;Iable I.
Because the tests of purity were done at different times over a 2-year period, the procedure used with each batch was not the same, and in batches A, B, C, and D, the specific activity just before chromatography was not determined. In subsequent lots, this was done, and there was a good agreement between the initial specific activity in lots E, F, and G and the final specific activtiy of the diacetate after chromatography in system F. In the earlier lots tested, there was a close correlation between the specific activity of the free aldosterone and its diacetate. This procedure demonstrated that the aldosterone-7a-H3 used was radiochemically homogeneous within the limits of our methods.
Urinary excretion and fractionation of radioactivity. Table II 97.6%o of that present in the 3-day urine appearing within the first 24 hours in normal subjects and in pregnant subjects, respectively. These data indicated that a 24-hour urine collection would suffice for the determination of aldosterone secretory rate, since 95% or more of the radioactivity present as tetrahydroaldosterone was excreted within this time. As a precaution, urine was collected for 2 days in all cases, although the first 24-hour urine collection was used for the determination of ASR.
In a large number of instances, crude urine counts were obtained on the second 24-hour urine. These did not reveal an appreciable excretion of radioactivity. In some instances, the metabolites in the second 24-hour urine were hydrolyzed, and tetrahydroaldosterone was isolated by paper chromatography. These experiments convinced us that at least 95% of the tetrahydroaldosterone was excreted in the first 24 hours, and since our estimation of the secretory rate was within 10%o, it weeks.
ASR at 4-week intervals on a constant dietary sodium. Because of wide fluctuations in ASR from one subject to the next, we decided to measure ASR at intervals of 4 weeks. with the subjects maintained on a constant sodium intake so that each subject could serve as her own control. The results are shown in Table VII , which includes some ASR measured serially in the two subjects shown in Table VI . With dietary sodium maintained at a constant level, there was a net increase in ASR over the four weeks of study in 14 of the 16 subjects. In two subjects (J1 at 30 to 34 weeks and M1 at 31 to 35 weeks), there was a net fall in ASR at week 4 of the study. The largest changes were noted when the second determination of ASR was performed in the last 4 weeks of pregnancy. This agrees with our earlier observations shown in Table V , where the average ASR seemed to increase in the last 4 weeks of pregnancy. Relatiowship between endogenous creatintine clearance anid ASR. Figure 1 shows the relationship between endogenous creatinine clearance, taken as an index of the quantity of sodium presented to the renal tubules by glomierular filtration, and the simultaneous ASR. The subjects were studied from weeks 30 through 37 of gestation with a dietary sodium intake of 120 to 190 mEq per day. No correlation was evident between the two values, either for the group as a whole or for subjects selected on the basis of shorter periods of gestation. Likewise, in a smaller number of subjects whose intake of sodium was more restricted, no correlation was evident between the glomerular filtration rate, as measured by the endogenous creatinine clearance, and ASR.
DISCUSSION
High urinary values of aldosterone have been reported in the last trimester of normal pregnancy by many investigators (19) (20) (21) (22) (23) (24) (25) . High urinary excretion of aldosterone was assumed to reflect an increased secretion of aldosterone by the adrenal gland, but the findings of Jones and associates (9) suggested that this high urinary excretion may not reflect a proportionate increased secretion of the hormone. Although Jones and associates noted increased aldosterone secretion in half of the pregnant subjects in their study, they postulated that the increased urinary excretion of aldosterone in pregnancy was due in part to an alteration in the metabolism of the hormone from that in normal nonpregnant subjects. They reported an increased metabolism of aldosterone to the 3-oxoconjugate and a decreased formation of the glucosiduronidates in pregnancy. The results obtained in our laboratory, however, do not support these findings. We cannot demonstrate any significant difference in the percentage of radioactivity released by acid hydrolysis or fl-glucuronidase hydrolysis of aldosterone metabolites in the urine of pregnant and nonpregnant subjects (Table II) . The radioactivity recovered as aldosterone and tetrahydroaldosterone after a single chromatographic separation on paper also showed no significant differences in the two groups (Table III) .
The results obtained in our laboratory and by other investigators are compared in Table X , which shows that there are some differences. These may be related to the variability among individual subjects. Between 40 and 50% of the injected radioactivity appears to be recovered in In the nonpregnant group, radioactivity released by pH 1 hydrolysis is the highest in our group of subjects. whereas radioactivity present as aldosterone compares with the results of others. There does not seem to be any significant difference in the percentage of radioactivity released by pH 1 hydrolysis for our normal subjects, our pregnant subjects, and the pregnant subjects of Jones and associates (9) . The radioactivity present as aldosterone is highest in this group (9) .
In six pregnant subjects, Jones (39) .
Evidence from many sources indicates that sodium is retained during pregnancy, and that this retained sodium is required to meet the needs of the fetus and secundinae. Sodium balance studies in the third trimester of pregnancy have pointed to a persistent retention of sodium (25, (40) (41) (42) (43) (44) (45) , variously estimated to be from 7 to 50 mEq per day. Chesley (45) has suggested 18 mEq per day as a representative figure for the amount of sodium retained in late pregnancy. Dieckmann and Pottinger (46) reported that even on a low-sodium intake of 9 mEq per day, two normal pregnant women accumulated 50 mEq of sodium per kg increase in body weight in the last trimester of pregnancy. Serial studies of Plentl and Gray (47) and of Davey, O'Sullivan, and Browne (48) indicated that there is a net increase in exchangeable sodium, averaging 510 mEq in the last two trimesters of pregnancy. This represented an average gain of 20 mEq of exchangeable sodium per week. The authors felt that this increment in exchangeable sodium could be accounted for in the products of gestation and the expanded maternal blood volume. Lichton (49) , in a study of pregnant rats, showed an average net accumulation of approximately 83 mEq of sodium per kg of weight gain throughout gestation. Of the total sodium retained, 15, 23, and 62% occurred in each successive third of the gestation. Analysis of the postpartum sodium balance and of fetal sodium at term indicated that there was no net accumulation of sodium in the tissues of the dams. The amount of sodium retained per kg weight gain of the pregnant dams was identical with the amount of sodium found in 1 kg of gravid uterus plus contents at term.
The absolute amount of sodium retained by the pregnant dams was also not significantly different from the total amount of sodium present in the fetal tissues.
The withdrawal of sodium from the mother for deposition in the fetus can be expected to stimulate the secretion of aldosterone. Under these circumstances, it would be reasonable for ASR to be influenced by the sodium available in the diet. When dietary sodium is restricted to about 10 mEq per day, the sodium sequestered into the growing fetus represents a larger portion of the ingested sodium. If at least 10 mEq of sodium per day is sequestered into the uterus and its contents, all of the ingested sodium would have to be retained when the diet contains 10 mnEq or less of sodium per day. Under these circumstances, a near maximal stimulation of aldosterone secretion by the adrenal gland may be expected.
The deposition of sodium into the uterus and its contents can be regarded as loss of sodium from the maternal vascular compartment. The mechanism of stimulation of aldosterone in pregnancy thus seems to be analagous to that proposed for experimental formation of ascites by Davis and associates (50, 51) . In those experiments, sequestration of sodium or fluid, or both, from the vascular compartment into the peritoneal cavity stimulated the secretion of aldosterone by the adrenal gland. Davis, Kliman, Yankopoulos, and Peterson (50) also found that the stimulation of aldosterone by the loss of fluid and electrolytes from the vascular tree in experimental ascites could not be offset by expansion of the intravascular volume. This might also explain the fact that increased secretion of aldosterone occurs in pregnancy despite increased plasma volume (52) and extracellular volume (53).
If the increased secretion of aldosterone seen in pregnancy is indeed a homeostatic mechanism for the conservation of sodium for both mother and fetus, the basal secretion of 1,100 jug per day would appear to be excessive for the task, since all subjects were receiving between 80 and 190 mEq of dietary sodium per day. Other factors must then be considered that are unique to pregnancy and that may stimulate the increased secretion observed. Two such factors are the large amounts of progesterone secreted by the placenta and the increased filtered load of sodium seen in pregnancy.
The natriuretic action of progesterone was reported in a series of articles by Landau and his co-workers (54) (55) (56) . This action was demon-strated to be due to an inhibition of aldosterone by progesterone, presumably at the renal tubular level. Martin and Mills (20) first suggested that this competitive interaction of the two steroids may explain the elevated excretion of aldosterone in pregnancy. A correlation between urinary pregnanediol excretion and aldosterone secretion was reported for normal pregnant subjects by Jones and associates (9) . Laidlaw, Ruse, and Gornall (57) demonstrated that exogenous progesterone could stimulate aldosterone secretion in normal nonpregnant subjects. No convincing natriuresis could be demonstrated, however, when progesterone was administered to three normal pregnant subjects by Landau, Plotz, and Lugibihl (58) . This lack of effect was attributed to the inability of the administered progesterone to inhibit the large amounts of aldosterone secreted in pregnancy.
A second factor requires consideration. The glomerular filtration rate and consequently the filtered sodium presented to the renal tubules for reabsorption may increase as much as 50% in pregnancy (59) . There is apparently no anatomical hypertrophy of the kidney in pregnancy (60) , and unless factors not yet defined increase sodium reabsorption under these conditions, the increase in filtered sodium may require an increase in the secretion of aldosterone for adequate retention. In order to determine whether there was a direct relationship in pregnancy between the filtered load of sodium and the aldosterone secreted, we measured these two parameters simultaneously in a number of pregnant subjects (Figure 1) . No correlation was observed between the glomerular filtration rate, as reflected by the endogenous creatinine clearance, and the aldosterone secretion rate. These findings do not exclude the possibility, however, that the increased glomerular filtration rate contributes to the increased secretion of aldosterone observed in pregnancy.
The optimal experimental design for demonstrating such a relationship would be the measurement of these two parameters in pregnant subjects at comparable weeks of gestation, with comparable sodium ingestion and progesterone secretion.
SUMMARY
All of the pregnant subjects studied had increased aldosterone secretion rates during the third trimester of pregnancy. Our data indicate that the metabolism of aldosterone is not altered in the pregnant as compared with the nonpregnant subj ect. The increased secretion of aldosterone may be seen as early as week 15 
